Please send me information on updates to the Act on PAH website and events, and relevant news, research and educational materials on PAH. Some of this information may be promotional in nature.
Actelion will ensure that your email address is only used to share materials that it considers to be appropriate, relevant and of value to you. To stop receiving these communications at any time, please follow the instruction on the latest email you receive from Actelion Pharmaceuticals UK Ltd.
By clicking subscribe, I confirm I am a UK based healthcare professional or relevant decision maker, I consent to Actelion Pharmaceuticals UK Ltd holding my email address within their customer database for the purposes of communicating with me as above, and understand that it will be held securely and not passed to any external company.